Rising BioSciences, Inc. signed a letter of intent to acquire Rising India INC. (OTCPK:RSII) in a reverse merger transaction on February 23, 2017. As of March 30, 2017, Rising BioSciences, Inc. executed the definitive agreement with Rising India Inc. As part of the transaction, the capital stockholders of Rising BioSciences will acquire control of Rising India toward immediate execution of a business model with a focus in alternative medical and cannabis pharmaceutical markets. Jim DiPrima, Chief Executive Officer of Rising India, has agreed to resign as an officer with the company making way for the appointment of Robert Weber, who also serves as Chief Executive Officer for PAO Group.